NCT07166003View on ClinicalTrials.gov

Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 20, 2025

Primary Completion Date

February 2, 2027

Study Completion Date

April 14, 2030

Conditions
Lung Cancer, Non-Small CellImmunotherapy
Interventions
PROCEDURE

Pneumonectomy

Patients will receive pneumonectomy after neoadjuvant treatment

PROCEDURE

lobectomy

Patients will receive lobectomy after neoadjuvant immunotherapy.

RADIATION

radiotherapy

Patients will receive radiotherapy after neoadjuvant immunotherapy.

DRUG

Anti-Tumor Drugs

Patients will receive anti-tumor drugs.

Trial Locations (1)

Unknown

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER